So in addition to improvement in growth rates, we also saw -- our margins were up. Laboratory profit margins were up 110 basis points, and the Hospital same-store gross profit margins were up 10 basis points. Canada, which we acquired on February 1, is doing great for the first 2 months of the quarter. They're performing -- for the 2 months in the quarter, they're performing ahead of our expectation. We're very, very excited to be up in Canada, and have our entire team as part of our management team.Our core business, as I said, Laboratory and Hospital businesses are doing quite well, but Vetstreet losses had a slightly negative impact on our results for the quarter. The increase in operating income in the Lab and Hospital segments of $7.5 million was offset by losses at Vetstreet and about a $5.2 million increase in our corporate SG&A costs due primarily to a $2.7 million increase in share-based comp, and about $880,000 of transaction costs related to AVC and ThinkPets acquisitions in the first quarter.
VCA Antech's CEO Discusses Q1 2012 Results - Earnings Call Transcript
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.